Peter Facchini's Insider Trades & SAST Disclosures
Peter Facchini's most recent trade in Enveric Biosciences Inc was a trade of 24,717 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter Facchini.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enveric Biosciences Inc | Peter Facchini | CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 24,717 | 33,058 (1%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Facchini Peter | CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 40,000 | 130,856 (4%) | 1% | 0 | Common Stock | |
| Enveric Biosciences Inc | Facchini Peter | CHIEF INNOVATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 90,856 (2%) | 1% | 0 | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 17,000 | 40,865 (1%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 10,500 | 23,856 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 1,021 | 13,356 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 531,602 | 531,602 (17%) | 17% | - | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 531,602 | 531,602 | - | - | Common Warrants | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 99,675 | 99,675 | - | - | Stock Options | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 85,056 | 85,056 (2%) | 2% | - | Common Stock | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 79,740 | 79,740 | - | - | Common Warrants | |
| Enveric Biosciences Inc | Peter Facchini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 2,658 | 2,658 | - | - | Common Warrants |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges